首页 >
法规速递
-
Page: ICH M14 guideline on general principles on plan, design and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines - Scientific guideline-2025/10/10
2025-10-11查看详情 > -
Page: Emergency Task Force (ETF)-2025/11/17
2025-11-18查看详情 > -
Document: Work plan for the Committee for Veterinary Medicinal Products (CVMP) Scientific Advice Working Party (SAWP-V) for 2026-2025/12/12
2025-12-15查看详情 > -
Page: Questions and answers on the use of Product Lifecycle Management (PLCM) document - Scientific guideline-2026/1/26
2026-01-27查看详情 > -
Document: Darwin EU study: Use of higher-risk antibiotics from the WHO Watch list, including azithromycin-2026/3/4
2026-03-05查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第一百零五批）》（征求意见稿）意见的通知-2026/4/1
2026-04-02查看详情 > -
Development of Non-Opioid Analgesics for Acute Pain-2026/5/13
2026-05-15查看详情 > -
Document: Medicine shortage communication (MSC): Topamax, Topimax, Epitomax, Topamac supply shortage-2026/6/29
2026-06-30查看详情 > -
Regulatory and procedural guideline: CAT rules of procedure-2022/11/17
2022-11-30查看详情 > -
国家药监局关于甲硝唑氯已定洗剂（浓）处方药转换为非处方药的公告（2023年第69号）-2023/5/31
2023-06-01查看详情 >
